About Fenwalinc
Fenwalinc is a company based in Lake Zurich (United States) founded in 1949 was acquired by Fresenius Kabi in July 2012.. Fenwalinc operates in a competitive market with competitors including Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
- Headquarter Lake Zurich, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Fenwal India Private Limited
- Date of Incorporation 18 Jan, 2007
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
$2.86 M (USD)-31.67as on Mar 31, 2016
-
Net Profit
$1.21 M (USD)753.83as on Mar 31, 2016
-
EBITDA
$305.63 K (USD)-9.22as on Mar 31, 2016
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Fresenius Kabi
(Jul 20, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Fenwalinc
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Fenwalinc
Fenwalinc has secured backing from 1 investor. Prominent investors backing the company include Fresenius Kabi. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare solutions in pharmaceuticals, nutrition, MedTech, and biopharmaceuticals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fenwalinc
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Fenwalinc
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Fenwalinc Comparisons
Competitors of Fenwalinc
Fenwalinc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a device for blood purification
|
|
| domain | founded_year | HQ Location |
Developer of the device for controlling bleeding
|
|
| domain | founded_year | HQ Location |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
|
| domain | founded_year | HQ Location |
Innovative solutions for safer blood transfusions are developed.
|
|
| domain | founded_year | HQ Location |
Cytopheresis systems for inflammatory conditions
|
|
| domain | founded_year | HQ Location |
Devices to facilitate blood component and bone marrow transplant
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Fenwalinc
When was Fenwalinc founded?
Fenwalinc was founded in 1949.
Where is Fenwalinc located?
Fenwalinc is headquartered in Lake Zurich, United States. It is registered at Lake Zurich, Illinois, United States.
What is the annual revenue of Fenwalinc?
Annual revenue of Fenwalinc is $2.86M as on Mar 31, 2016.
What does Fenwalinc do?
Fenwal(acquired by Fresenius Kabi in 2012) is a blood technology company producing products to support transfusion medicine and cell therapy. Its offerings include medical technologies used in blood separation, collection, filtration, storage and transfusion. Some of its products are component collection systems, separators, and plasmapheresis systems, manual collection products, segment sampling devices, tubing sealers, sterile tube connection systems, hemoglobin screening devices, donor chairs, donor tube strippers, transfer packs, transfusion sets, platelet and cellular sample transfer kits, bone marrow kits. Fenwal Inc. was owned by Baxter Healthcare Corporation till 2007 when it was sold by Baxter to Texas Pacific Group (TPG) and Maverick Capital. In 2012, it was acquired by Fresenius Kabi.
Who are the top competitors of Fenwalinc?
Fenwalinc's top competitors include Medcura, ExThera Medical and Lindis Blood Care.
Who are Fenwalinc's investors?
Fenwalinc has 1 investor. Key investors include Fresenius Kabi.